959
Views
40
CrossRef citations to date
0
Altmetric
Review Article

Novel drugs from marine microorganisms

, , &
Pages 245-249 | Received 05 Mar 2011, Accepted 25 Mar 2011, Published online: 20 May 2011

References

  • Ablan S., Rawat S., Viard M, Wang J, Puri A, Blumenthal R. (2006). The role of cholesterol and sphingolipids in chemokine receptor function and HIV-1 envelope glycoprotein-mediated fusion. Virol J, 3, 104.
  • Adolf JE, Bachvaroff TR, Place AR. (2009). Environmental modulation of karlotoxin levels in strains of the cosmopolitan dinoflagellate, Karlodinium veneficum (Dinophyceae). J Phycol, 45, 176–192.
  • Agargun M, Dulger H, Inci R, Kara H, Ozer O, Sekeroglu M, Besiroglu L. (2004). Serum lipid concentrations in obsessive-compulsive disorder patients with and without panic attacks. Can J Psychiatry, 49, 776–778.
  • Alchorn A. (2007). Lipid rafts observed in cell membranes. Sci Tech Rev, 9.
  • Bachvaroff TR, Adolf JE, Squier AH, Harvey HR, Place AR. (2008). Characterization and quantification of karlotoxins by liquid chromatography-mass spectrometry. Harmful Algae, 7, 473–484.
  • Baldwin JE. (1992). Biosynthesis of manzamines, Tetrahedron Lett, 33, 2059–2062.
  • Berg J, Tymoczko J, Stryer L. (2002). The Biosynthesis of Membrane Lipids and Steroids. Biochemistry by W.H. Freeman and Company. Chapter 26. 6th Edition.
  • Cabrita MT, Vale C, Rauter AP. (2010). Halogenated compounds from marine algae. J Nat, 8(8), 2301–2317.
  • Cuevas C, Francesch A. (2009). Development of Yondelis (trabectedin, ET-743): a semisynthetic process solves the supply problem. Nat Prod Rep, 26, 322–337.
  • Cuevas C, Perez M, Martin MJ, Chicharro JL, Fernandez-Rivas C, Flores M, Francesch A, Gallego P, Zarzuelo M, de la Calle F. (2002). Synthesis of ecteinascidin ET-743 and phthalascidin Pt-650 from cyanosafracin B. Org Lett, 2, 2545–2548.
  • Demydchuk Y, Sun Y, Hong H, Staunton J, Spencer JB, Leadlay PF. (2008). Analysis of the tetronomycin gene cluster: insights into the biosynthesis of a polyether tetronate antibiotic. Chembiochem, 9, 1136–1145.
  • Fantini F, Barrantes F. (2009). Sphingolipid/cholesterol regulation of neurotransmitter receptor conformation and function. Biochim Biophys Acta, 1788. 2345–2361.
  • Fantini J, Garmy N, Mahfoud R, Yahi N. (2002). Lipid rafts: structure, function and role in HIV, Alzheimer’s and prion diseases. Expert Rev Mol Med, 4(27), 1–22.
  • Guo YQ, Warwick RM, Zhang ZN, Mu FH. (2002). Free living marine nematodes as pollution indicator. J Environ Sci, 14(4), 558–62.
  • Harvey BM, Mironenko T, Sun Y, Hong H, Deng Z, Leadlay PF, Weissman KJ, Haydock SF. (2007). Insights into polyether biosynthesis from analysis of the nigericin biosynthetic gene cluster in Streptomyces sp. DSM4137. Chem Biol, 14, 703–714.
  • Hentschel U, Usher KM, Tavior MVV. (2007). Marine sponges as microbial fermentor. J Nat Prod, 16, 275–279.
  • Hill RT, Hamann MT, Peraud O, Kasanah N. (2004). Manzamine Producing Actinomycetes. National center for natural product research, USA. WO 2004/013297A3.
  • Hoshi M, Endo T. (2000). Microbial and chemical conversion of antibiotic K41. II. Preparation of K41-DA1-DA2 and -DA3 deamicetosyl derivatives of antibiotic K41. J Antibiot (Tokyo). 53, 1154–1157.
  • Jayakumar R, Chennazhi KP, Anitha A, Ehrlich H, Tamura H, Nair SV. (2010). Chitin of Marine Origin: Membranes, Scaffolds and Their Biomedical Applications, Special issue marine functional food. MDPI, 55(7), 675–709.
  • Kijjojoa A, Sawangwong P. (2004). Drugs and cosmetics from the sea. J MDPI, 2, 73–82.
  • Kobayashi M, Natsume T, Tamaoki S, Watanabe J, Asano H, Mikami T, Miyasaka K, Miyazaki K, Gondo M, Sakakibara K. (1997). Antitumor activity of TZT-1027, a novel dolastatin 10 derivative. Jpn J Cancer, 88, 316–327.
  • Luo C, Wang K, Liu D, Li Y, Zhao O. (2008). The functional roles of lipid rafts in T cell activation, immune diseases and HIV infection and prevention. Cell Mol Immunol, 5, 1–7.
  • Mikami Y, Takahashi K, Yazawa K, Arai T, Namikoshi M, Iwasaki S, Okuda S. (1985). Biosynthetic studies on saframycin A, a quinone antitumor antibiotic produced by Streptomyces lavendulae. J Biol Chem, 260, 344–348.
  • Newman DJ, Cragg GM, Snader KM. (2000). The influence of natural products upon drug discovery. Nat Prod Rep, 17, 215–234.
  • Newman DJ, Cragg GM, Snader KM. (2003). Natural products as a source of new drugs over the period 1981–2002. J Nat Prod, 66, 1022–1037.
  • Newman SE, Eribulin. (2007). A simplified ketone analog of the tubulin inhibitor halichondrin B, for the potential treatment of cancer. Curr Opin Investig Drugs, 8, 1057–1066.
  • Ocio EM, Maiso P, Chen X, Garayoa M, Alvarez-Fernandez S, San-Segundo L, Vilanova D, Lopez-Corral L, Montero JC, Hernandez-Iglesias T. (2009). Zalypsis: a novel marine-derived compound with potent antimyeloma activity that reveals high sensitivity of malignant plasma cells to DNA double-strand breaks. Nature Prod, 113, 3781–3791.
  • Oftedal L, Selheim F, Wahlsten M, Sivonen K, Døskeland SO, Herfindal L. (2010). Marine cynobacteria contain apoptosis inducing activity synergizing with daunorubicin to kill leukemia cells but not cardiomyocytes. J Nat Prod, 8(10), 2659–2672.
  • Pandey SC, Sassetti C. (2008). Mycobacterial persistence requires the utilization of host cholesterol. Proc Natl Acad Sci, 105, 4376–4380.
  • Peng J, Hill R, Place A, Anklin C, Hamann MT. (2007). Marine microbes: the critical role they play in sustainable production of starting materials for the synthesis of drug leads and the structure for the elusive Pfiesteria-associated fish killing toxin using 13C enrichment and dual cryoprobe NMR studies. Papers, United States. 25–29.
  • Peng J, Kudrimoti S, Prasanna S, Odde S, Doerksen RJ, Pennaka HK, Choo Y, Rao KV, Tekwani BL, Madgula V. (2010). Structure-activity relationship and mechanism of action studies of manzamine analogues for the control of neuroinflammation and cerebral infections. J Med Chem, 53, 61–76.
  • Peng J, Place AR, Yoshida W, Clemens A, Hamann MT. (2010). Structure and absolute configuration of karlotoxin-2, an ichthyotoxin from the marine dinoflagellate Karlodinium veneficum. J Am Chem Soc, 132, 3277–3279.
  • Penseyan A, Kielleberg Egan S. (2010). Development of novel drugs from marine microorganisms. Nature, 8(3), 438–59.
  • Place AR, Bai X, Kim S, Sengco MR, Coats DW. (2009). Dinoflagellate host-parasite sterol profiles dictate karlotoxin sensitivity. J Phycol, 45, 375–385.
  • Place AR, Deeds JR. (2004). Dinoflagellate Karlotoxins, Methods of Isolation and Uses Thereof. WO 2004/100659 A2. 21, 780–726.
  • Qadir MI, Malik SA. (2011). Genetic Variation in the HR Region of the env Gene of HIV: A Perspective for Resistance to HIV Fusion Inhibitors. AIDS Res Hum Retrovir, 27(1): 57–63.
  • Qadir MI, Malik SA. (2010). HIV Fusion Inhibitors. Rev Med Virol, 20:23–33. DOI: 10.1002/rmv.631
  • Rinehart (2000). Antitumor compounds from tunicates. Med Res Rev, 20, 1–27.
  • Rinehart KL, Bible V, Sakai KC, Sullins R, Li DW, Didemnins KM, Tunichlorin. (1998). Novel natural products from the marine Tunicates. J Nat Prod, 51, 1–21.
  • Scheuer PJ. (1996). Marine metabolites as Drug Leads Retrospect and prospects: Colorado. J Nat, 1–12.
  • Sheng J, Malkiel E, Katz J, Adolf JE, Place AR. (2010). A dinoflagellate exploits toxins to immobilize prey prior to ingestion. Proc Natl Acad Sci, 107, 2082–2087.
  • Simons K, Ehehalt R. (2002). Cholesterol, lipid rafts and disease. J Clin Invest, 110, 597–603.
  • Van Wagoner RM, Deeds JR, Satake M, Ribeiro AA, Place AR, Wright JLC. (2008). Isolation and characterization of karlotoxin 1, a new amphipathic toxin from Karlodimiun veneficum. Tetrahedron Lett, 49, 6457–6461.
  • Wang D. (2008). Neurotoxins from marine dinoflagellates: a brief review. Mar Drugs, 6, 349–371.
  • Yamada K, Okijia M, Kigoshi H, Suenaga, Kigoshi HS. (2000). Cytotoxic substances from Opisthobranch molluscs, in drugs from the sea. Basel, 59–73.
  • Zewail-Foote M, Hurley L, Ecteinascidin H. (1999). A minor groove alkylator that binds DNA towards the major groove. J Med Chem, 42, 2493–2497.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.